New Report Available: Bulgaria Pharmaceuticals & Healthcare Report Q2 2013
Following reports of drugmarkers' non-compliance with negotiated pharmaceutical prices, which has led to the National Health Insurance Fund (NHIF) paying significantly more for reimbursed medicines, we expect the public backlash and political manoeuvring by opposition parties to force the government to mandate currently voluntary price discounts through legislation. The potential introduction of additional restrictive policies - on top of the implemented mark-up ceilings for wholesalers and manufacturers and the expansion of countries in the reference pricing list - will inevitably...
View full press release